A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Washington
SWOG Cancer Research Network
Queen Mary University of London
Stanford University
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Hellenic Oncology Research Group
University of Chicago
Memorial Sloan Kettering Cancer Center
Northside Hospital, Inc.
European Organisation for Research and Treatment of Cancer - EORTC
Fred Hutchinson Cancer Center